Among PDA tumours of the TCGA cohort, low TILs levels indicated a worse patients’ survival but only when MAF had lower expression, which is in line with the antagonist interaction between Maf+ macrophages and CD8+ T cells that we found in ODI. The gene discussed is CD8A; the disease is Patent ductus arteriosus.